Cold chain integrity for reagents and vaccines: what can go wrong, and where

Temperature-sensitive reagents, controls, and vaccines are usually well protected at the two ends of the supply chain — in a manufacturer's climate-controlled warehouse, and in a laboratory's own fridge. The highest-risk points are almost always in between: customs holding areas, last-mile road transport in hot climates, and repeated door-opening during shift handovers.

Where integrity typically breaks down

Transit gaps. A cold box rated for 48 hours can fail if a shipment sits at a customs facility for longer than planned, with no active monitoring to flag it.

Last-mile transport. The final leg — from a regional distribution point to a rural facility — is frequently the least monitored, and often the hottest.

Facility-level storage. Power outages, generator gaps, and fridges shared between reagents and unrelated stock are common, avoidable failure points.

Data gaps, not just temperature gaps. A shipment that stayed in range but has no continuous temperature record is, from a quality-audit perspective, almost as hard to defend as one that excursed — you cannot prove integrity you didn't measure.

What good practice looks like

Continuous data-logging (not spot checks), a documented excursion response procedure, redundant power at the storage point, and a chain-of-custody record from dispatch to bench are the standard a quality auditor will look for. VIVACARE's cold-chain procedures and monitoring methodology are being published to the Trust & Compliance Centre — where evidence is not yet published, that is stated plainly rather than assumed.